UBE3A/E6-AP mutations cause Angelman syndrome

Area of Science:

• Genetics
• Neuroscience
• Developmental Biology

Background:

• Angelman syndrome (AS) is a neurodevelopmental disorder linked to genetic imprinting.
• Common causes include maternal deletions or paternal uniparental disomy (UPD) of chromosome 15.
• A significant portion of AS cases lack these genetic abnormalities, suggesting other genetic factors.

Purpose of the Study:

• To investigate the role of the UBE3A gene in Angelman syndrome.
• To identify novel UBE3A mutations in AS patients without detectable deletions, UPD, or imprinting mutations.
• To explore the functional consequences of identified mutations on protein ubiquitination and brain development.

Main Methods:

• Sequence analysis of the UBE3A gene in AS patients.
• Investigated a 15q inversion disrupting UBE3A in a familial AS case.
• Identified and characterized de novo duplication and splice-site mutations in UBE3A.

Main Results:

• A 15q inversion disrupting the UBE3A gene was identified in a familial AS case.
• Novel UBE3A mutations, including a tandem duplication and a splice-site mutation, were found in nondeletion/non-UPD AS patients.
• These mutations are predicted to cause frameshifts and premature protein termination, affecting ubiquitin-mediated protein degradation.

Conclusions:

• Mutations in the UBE3A gene are a cause of Angelman syndrome.
• UBE3A gene mutations disrupt protein ubiquitination, potentially leading to neurodevelopmental deficits in AS.
• Further research into ubiquitin-mediated protein degradation is warranted for understanding AS pathogenesis.